{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T02:53:39Z","timestamp":1790650419424,"version":"4.1.0"},"reference-count":43,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2021,11,1]],"date-time":"2021-11-01T00:00:00Z","timestamp":1635724800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81772827"],"award-info":[{"award-number":["81772827"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Genet."],"abstract":"<jats:p><jats:bold>Background:<\/jats:bold> Although ribosomal protein S6 kinases, 90\u00a0kDa, polypeptide 3 (<jats:italic>RSK2<\/jats:italic>, <jats:italic>RPS6KA3<\/jats:italic>) has been reported to play an important role in cancer cell proliferation, invasion, and migration, including breast cancer, its clinical implication in primary breast cancer patients is not well understood, and there were not many studies to explore the relationship between <jats:italic>RSK2<\/jats:italic> and breast cancer on a clinical level.<\/jats:p><jats:p><jats:bold>Methods:<\/jats:bold> A systematic series matrix file search uploaded from January 1, 2008 to November 31, 2017 was undertaken using ArrayExpress and Gene Expression Omnibus (GEO) databases. Search filters were breast cancer, RNA assay, and array assay. Files eligible for inclusion met the following criteria: a) sample capacity is over 100, b) tumor sample comes from unselected patient\u2019s primary breast tumor tissue, and c) expression of <jats:italic>RSK2<\/jats:italic> and any clinical parameters of patients were available from the files. We use median as the cutoff value to assess the association between the expression of <jats:italic>RSK2<\/jats:italic> and the clinical indexes of breast cancer patients.<\/jats:p><jats:p><jats:bold>Finding:<\/jats:bold> The meta-analysis identified 13 series matrix files from GEO database involving 3,122 samples that come from patients\u2019 primary breast cancer tissue or normal tissue. The expression of <jats:italic>RSK2<\/jats:italic> in tumor tissues is lower than that in normal tissues [odds ratio (OR), 0.54; 95% credible interval (CI), 0.44\u20130.67; Cochran\u2019s <jats:italic>Q<\/jats:italic> test <jats:italic>p<\/jats:italic> = 0.14; <jats:italic>I<\/jats:italic><jats:sup>2<\/jats:sup> = 41.7%]. Patients with a high expression of <jats:italic>RSK2<\/jats:italic> showed more favorable overall survival [hazard ratio (HR), 0.71; 95% CI, 0.49\u20130.94; Cochran\u2019s <jats:italic>Q<\/jats:italic> test <jats:italic>p<\/jats:italic> = 0.95; <jats:italic>I<\/jats:italic><jats:sup>2<\/jats:sup> = 0.0%] and less potential of distant metastasis (OR, 0.59; 95% CI, 0.41\u20130.87; Cochran\u2019s <jats:italic>Q<\/jats:italic> test <jats:italic>p<\/jats:italic> = 0.88; <jats:italic>I<\/jats:italic><jats:sup>2<\/jats:sup> = 0.0%) and lymph node infiltration (OR, 0.81; 95% CI, 0.65\u20130.998; Cochran\u2019s <jats:italic>Q<\/jats:italic> test <jats:italic>p<\/jats:italic> = 0.09; <jats:italic>I<\/jats:italic><jats:sup>2<\/jats:sup> = 42.8%). Besides, the expression of <jats:italic>RSK2<\/jats:italic> in luminal breast cancer is lower than Cochran\u2019s <jats:italic>Q<\/jats:italic> test <jats:italic>p<\/jats:italic> = 0.06; <jats:italic>I<\/jats:italic><jats:sup>2<\/jats:sup> = 63.5%). <jats:italic>RSK2<\/jats:italic> overexpression corresponded with higher histological grade (OR, 1.329; 95% CI, 1.03\u20131.721; Cochran\u2019s <jats:italic>Q<\/jats:italic> test <jats:italic>p<\/jats:italic> = 0.69; <jats:italic>I<\/jats:italic><jats:sup>2<\/jats:sup> = 0.0%). <jats:italic>RSK2<\/jats:italic> expression is also associated with estrogen receptor (ER) and age.<\/jats:p><jats:p><jats:bold>Conclusion:<\/jats:bold> The meta-analysis provides evidence that <jats:italic>RSK2<\/jats:italic> is a potential biomarker in breast cancer patients. The expression of <jats:italic>RSK2<\/jats:italic> is distinctive in different intrinsic subtypes of breast cancer, indicating that it may play an important role in specific breast cancer. Further study is needed to uncover the mechanism of <jats:italic>RSK2<\/jats:italic> in breast cancer.<\/jats:p><jats:p><jats:bold>Systematic Review Registration:<\/jats:bold> (website), identifier (registration number).<\/jats:p>","DOI":"10.3389\/fgene.2021.770134","type":"journal-article","created":{"date-parts":[[2021,11,1]],"date-time":"2021-11-01T06:13:50Z","timestamp":1635747230000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":10,"title":["Association Between RSK2 and Clinical Indexes of Primary Breast Cancer: A Meta-Analysis Based on mRNA Microarray Data"],"prefix":"10.3389","volume":"12","author":[{"given":"Kun","family":"Zheng","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuo","family":"Yao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Yao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qianxia","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yali","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lili","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiuqiong","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huihua","family":"Xiong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xianglin","family":"Yuan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yihua","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yanmei","family":"Zou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hua","family":"Xiong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2021,11,1]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"5412","DOI":"10.1038\/onc.2016.79","article-title":"RSK2 Signals through Stathmin to Promote Microtubule Dynamics and Tumor Metastasis","volume":"35","author":"Alesi","year":"2016","journal-title":"Oncogene"},{"key":"B2","unstructured":"ArrayExpress2017"},{"key":"B3","doi-asserted-by":"publisher","first-page":"201","DOI":"10.3389\/fonc.2013.00201","article-title":"A Rising Cancer Prevention Target of RSK2 in Human Skin Cancer","volume":"3","author":"Arul","year":"2013","journal-title":"Front. Oncol."},{"key":"B4","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1007\/s10549-008-0105-3","article-title":"Effects of Infiltrating Lymphocytes and Estrogen Receptor on Gene Expression and Prognosis in Breast Cancer","volume":"116","author":"Calabr\u00f2","year":"2009","journal-title":"Breast Cancer Res. Treat."},{"key":"B5","doi-asserted-by":"publisher","first-page":"683","DOI":"10.1038\/nrclinonc.2010.154","article-title":"Triple-negative Breast Cancer: Disease Entity or Title of Convenience","volume":"7","author":"Carey","year":"2010","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"B6","doi-asserted-by":"publisher","first-page":"1744","DOI":"10.1158\/1078-0432.CCR-07-1833","article-title":"A Gene Expression Signature that Can Predict the Recurrence of Tamoxifen-Treated Primary Breast Cancer","volume":"14","author":"Chanrion","year":"2008","journal-title":"Clin. Cancer Res."},{"key":"B7","doi-asserted-by":"publisher","first-page":"3484","DOI":"10.1093\/emboj\/20.13.3484","article-title":"Rsk2 Allosterically Activates Estrogen Receptor Alpha by Docking to the Hormone-Binding Domain","volume":"20","author":"Clark","year":"2001","journal-title":"EMBO J."},{"key":"B8","doi-asserted-by":"publisher","first-page":"2300","DOI":"10.1093\/carcin\/bgt208","article-title":"Correlating Transcriptional Networks to Breast Cancer Survival: a Large-Scale Coexpression Analysis","volume":"34","author":"Clarke","year":"2013","journal-title":"Carcinogenesis"},{"key":"B9","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1007\/978-1-4939-3578-9_5","article-title":"The Gene Expression Omnibus Database","volume":"1418","author":"Clough","year":"2016","journal-title":"Methods Mol. Biol."},{"key":"B10","doi-asserted-by":"publisher","first-page":"13721","DOI":"10.1007\/s13277-016-5266-9","article-title":"Interactions between FGFR2 and RSK2-Implications for Breast Cancer Prognosis","volume":"37","author":"Czaplinska","year":"2016","journal-title":"Tumor Biol."},{"key":"B11","doi-asserted-by":"publisher","first-page":"1437","DOI":"10.1002\/stem.1707","article-title":"YB-1 Transforms Human Mammary Epithelial Cells through Chromatin Remodeling Leading to the Development of Basal-like Breast Cancer","volume":"32","author":"Davies","year":"2014","journal-title":"Stem Cells"},{"key":"B12","doi-asserted-by":"publisher","first-page":"722","DOI":"10.1016\/j.molcel.2008.06.025","article-title":"Codependent Functions of RSK2 and the Apoptosis-Promoting Factor TIA-1 in Stress Granule Assembly and Cell Survival","volume":"31","author":"Eisinger-Mathason","year":"2008","journal-title":"Mol. Cel"},{"key":"B13","doi-asserted-by":"publisher","first-page":"e16915","DOI":"10.1371\/journal.pone.0016915","article-title":"miRNA-mRNA Integrated Analysis Reveals Roles for miRNAs in Primary Breast Tumors","volume":"6","author":"Enerly","year":"2011","journal-title":"PLoS One"},{"key":"B14","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1016\/s0303-7207(99)00061-1","article-title":"Role and Regulation of 90 kDa Ribosomal S6 Kinase (RSK) in Signal Transduction","volume":"151","author":"Fr\u00f6din","year":"1999","journal-title":"Mol. Cel Endocrinol"},{"key":"B15","doi-asserted-by":"publisher","first-page":"527","DOI":"10.15252\/emmm.201505891","article-title":"Chronic Oxidative Stress Promotes H2 AX Protein Degradation and Enhances Chemosensitivity in Breast Cancer Patients","volume":"8","author":"Gruosso","year":"2016","journal-title":"EMBO Mol. Med."},{"key":"B16","doi-asserted-by":"publisher","first-page":"187","DOI":"10.3892\/ol.2021.12448","article-title":"Akt Regulates RSK2 to Alter Phosphorylation Level of H2A.X in Breast Cancer","volume":"21","author":"Guo","year":"2021","journal-title":"Oncol. Lett."},{"key":"B17","doi-asserted-by":"publisher","first-page":"R65","DOI":"10.1186\/bcr2632","article-title":"Expression Levels of Uridine 5'-Diphospho-Glucuronosyltransferase Genes in Breast Tissue from Healthy Women Are Associated with Mammographic Density","volume":"12","author":"Haakensen","year":"2010","journal-title":"Breast Cancer Res."},{"key":"B18","doi-asserted-by":"publisher","first-page":"e0174515","DOI":"10.1371\/journal.pone.0174515","article-title":"Mining Expression and Prognosis of Topoisomerase Isoforms in Non-small-cell Lung Cancer by Using Oncomine and Kaplan-Meier Plotter","volume":"12","author":"Hou","year":"2017","journal-title":"PLoS One"},{"key":"B19","doi-asserted-by":"publisher","first-page":"1016","DOI":"10.1002\/cam4.442","article-title":"Molecular Portrait of Breast Cancer in China Reveals Comprehensive Transcriptomic Likeness to Caucasian Breast Cancer and Low Prevalence of Luminal A Subtype","volume":"4","author":"Huang","year":"2015","journal-title":"Cancer Med."},{"key":"B20","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1186\/1471-2407-11-143","article-title":"Correlation of Microarray-Based Breast Cancer Molecular Subtypes and Clinical Outcomes: Implications for Treatment Optimization","volume":"11","author":"Kao","year":"2011","journal-title":"BMC Cancer"},{"key":"B21","unstructured":"Kaplan-meier Plotter"},{"key":"B22","doi-asserted-by":"publisher","first-page":"e84343","DOI":"10.1371\/journal.pone.0084343","article-title":"RSK2 Is a Modulator of Craniofacial Development","volume":"9","author":"Laugel-Haushalter","year":"2014","journal-title":"PLoS One"},{"key":"B23","doi-asserted-by":"publisher","first-page":"576","DOI":"10.1186\/s12885-015-1580-7","article-title":"Magnolin Inhibits Cell Migration and Invasion by Targeting the ERKs\/RSK2 Signaling Pathway","volume":"15","author":"Lee","year":"2015","journal-title":"BMC Cancer"},{"key":"B24","doi-asserted-by":"publisher","first-page":"455","DOI":"10.1158\/1940-6207.CAPR-12-0425","article-title":"Direct Targeting of MEK1\/2 and RSK2 by Silybin Induces Cell-Cycle Arrest and Inhibits Melanoma Cell Growth","volume":"6","author":"Lee","year":"2013","journal-title":"Cancer Prev. Res."},{"key":"B25","doi-asserted-by":"publisher","first-page":"214","DOI":"10.1038\/nm.2090","article-title":"Amplification of LAPTM4B and YWHAZ Contributes to Chemotherapy Resistance and Recurrence of Breast Cancer","volume":"16","author":"Li","year":"2010","journal-title":"Nat. Med."},{"key":"B26","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1007\/s10549-007-9596-6","article-title":"Predicting Features of Breast Cancer with Gene Expression Patterns","volume":"108","author":"Lu","year":"2008","journal-title":"Breast Cancer Res. Treat."},{"key":"B27","doi-asserted-by":"publisher","first-page":"2014","DOI":"10.1158\/0008-5472.CAN-17-2063","article-title":"ER\u03b1-Mediated Nuclear Sequestration of RSK2 Is Required for ER+ Breast Cancer Tumorigenesis","volume":"78","author":"Ludwik","year":"2018","journal-title":"Cancer Res."},{"key":"B28","doi-asserted-by":"publisher","first-page":"1159","DOI":"10.1158\/1541-7786.MCR-16-0158","article-title":"Melatonin Represses Metastasis in Her2-Postive Human Breast Cancer Cells by Suppressing RSK2 Expression","volume":"14","author":"Mao","year":"2016","journal-title":"Mol. Cancer Res."},{"key":"B29","unstructured":"Gene Expression Omnibus2017"},{"key":"B30","doi-asserted-by":"publisher","first-page":"946","DOI":"10.1158\/1078-0432.CCR-16-1278","article-title":"High-Risk Premenopausal Luminal A Breast Cancer Patients Derive No Benefit from Adjuvant Cyclophosphamide-Based Chemotherapy: Results from the DBCG77B Clinical Trial","volume":"23","author":"Nielsen","year":"2017","journal-title":"Clin. Cancer Res."},{"key":"B31","doi-asserted-by":"publisher","first-page":"D747","DOI":"10.1093\/nar\/gkl995","article-title":"ArrayExpress--a Public Database of Microarray Experiments and Gene Expression Profiles","volume":"35","author":"Parkinson","year":"2007","journal-title":"Nucleic Acids Res."},{"key":"B32","doi-asserted-by":"publisher","first-page":"747","DOI":"10.1038\/35021093","article-title":"Molecular Portraits of Human Breast Tumours","volume":"406","author":"Perou","year":"2000","journal-title":"Nature"},{"key":"B33","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1186\/s12916-015-0540-z","article-title":"Response and Survival of Breast Cancer Intrinsic Subtypes Following Multi-Agent Neoadjuvant Chemotherapy","volume":"13","author":"Prat","year":"2015","journal-title":"BMC Med."},{"key":"B34","doi-asserted-by":"publisher","first-page":"7","DOI":"10.3322\/caac.21442","article-title":"Cancer Statistics, 2018","volume":"68","author":"Siegel","year":"2018","journal-title":"CA: A Cancer J. Clinic."},{"key":"B35","doi-asserted-by":"publisher","first-page":"1338","DOI":"10.1002\/stem.1128","article-title":"Targeting P90 Ribosomal S6 Kinase Eliminates Tumor-Initiating Cells by Inactivating Y-Box Binding Protein-1 in Triple-Negative Breast Cancers","volume":"30","author":"Stratford","year":"2012","journal-title":"Stem Cells"},{"key":"B36","doi-asserted-by":"publisher","first-page":"2008","DOI":"10.1001\/jama.283.15.2008","article-title":"Meta-analysis of Observational Studies in EpidemiologyA Proposal for Reporting","volume":"283","author":"Stroup","year":"2000","journal-title":"JAMA"},{"key":"B37","doi-asserted-by":"publisher","first-page":"6099","DOI":"10.1158\/0008-5472.CAN-13-1087","article-title":"RSK Isoforms in Cancer Cell Invasion and Metastasis","volume":"73","author":"Sulzmaier","year":"2013","journal-title":"Cancer Res."},{"key":"B38","doi-asserted-by":"publisher","first-page":"398","DOI":"10.1172\/JCI71180","article-title":"MYC-driven Accumulation of 2-hydroxyglutarate Is Associated with Breast Cancer Prognosis","volume":"124","author":"Terunuma","year":"2014","journal-title":"J. Clin. Invest."},{"key":"B39","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1016\/j.celrep.2014.08.073","article-title":"The Prognostic Ease and Difficulty of Invasive Breast Carcinoma","volume":"9","author":"Tofigh","year":"2014","journal-title":"Cel Rep."},{"key":"B40","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1007\/s12672-015-0235-0","article-title":"Alcohol Consumption and Risk of Breast Cancer by Tumor Receptor Expression","volume":"6","author":"Wang","year":"2015","journal-title":"Horm. Canc"},{"key":"B41","doi-asserted-by":"publisher","first-page":"958","DOI":"10.1158\/1940-6207.CAPR-14-0126","article-title":"Kaempferol Targets RSK2 and MSK1 to Suppress UV Radiation-Induced Skin Cancer","volume":"7","author":"Yao","year":"2014","journal-title":"Cancer Prev. Res."},{"key":"B42","doi-asserted-by":"publisher","first-page":"1994","DOI":"10.3390\/ijms20081994","article-title":"RSK2-Mediated ELK3 Activation Enhances Cell Transformation and Breast Cancer Cell Growth by Regulation of C-Fos Promoter Activity","volume":"20","author":"Yoo","year":"2019","journal-title":"Int. J. Mol. Sci."},{"key":"B43","first-page":"1267","article-title":"The Clinical Implications of RSK1-3 in Human Breast Cancer","volume":"36","author":"Zhao","year":"2016","journal-title":"Anticancer Res."}],"container-title":["Frontiers in Genetics"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fgene.2021.770134\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,11,1]],"date-time":"2021-11-01T06:13:54Z","timestamp":1635747234000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fgene.2021.770134\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,11,1]]},"references-count":43,"alternative-id":["10.3389\/fgene.2021.770134"],"URL":"https:\/\/doi.org\/10.3389\/fgene.2021.770134","relation":{},"ISSN":["1664-8021"],"issn-type":[{"value":"1664-8021","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,11,1]]},"article-number":"770134"}}